Search Results

There are 6421 results for: content related to: Ribavirin in the treatment of chronic hepatitis C

  1. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  2. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  3. You have free access to this content
    Guidelines for the Management of Hepatitis C Virus Infection

    Hepatology Research

    Volume 43, Issue 1, January 2013, Pages: 1–34, Editors of the Drafting Committee for Hepatitis Management Guidelines: The Japan Society of Hepatology

    Version of Record online : 18 JAN 2013, DOI: 10.1111/hepr.12020

  4. Hepatitis C

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt033

  5. Ribavirin monotherapy for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Jesper Brok, Lise Lotte Gluud and Christian Gluud

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD005527.pub2

  6. You have free access to this content
    Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud and Lise Lotte Gluud

    Published Online : 28 FEB 2014, DOI: 10.1002/14651858.CD005441.pub3

  7. You have full text access to this OnlineOpen article
    Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection

    Liver International

    Volume 37, Issue 1, January 2017, Pages: 5–18, Jordan J. Feld, Ira M. Jacobson, Mark S. Sulkowski, Fred Poordad, Fernando Tatsch and Jean-Michel Pawlotsky

    Version of Record online : 29 SEP 2016, DOI: 10.1111/liv.13212

  8. Ribavirin plus interferon versus interferon for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Jesper Brok, Lise Lotte Gluud and Christian Gluud

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD005445.pub2

  9. You have free access to this content
    Synthesis and Evaluation of Bile Acid–Ribavirin Conjugates as Prodrugs to Target the Liver

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 9, September 2015, Pages: 2864–2876, Zhongqi Dong, Qing Li, Dong Guo, Yan Shu and James E. Polli

    Version of Record online : 2 FEB 2015, DOI: 10.1002/jps.24375

  10. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  11. Impact of ribavirin dose reduction on the efficacy of pegylated interferon plus ribavirin combination therapy for elderly patients infected with genotype 1b and high viral loads

    Hepatology Research

    Volume 41, Issue 7, July 2011, Pages: 626–634, Hiroshi Kohno, Hirotaka Kouno, Shiomi Aimitsu, Yasuyuki Aisaka, Mikiya Kitamoto, Hiroiku Kawakami and Kazuaki Chayama

    Version of Record online : 28 JUN 2011, DOI: 10.1111/j.1872-034X.2011.00811.x

  12. Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin

    Journal of Viral Hepatitis

    Volume 16, Issue 8, August 2009, Pages: 586–594, N. Hiramatsu, T. Oze, T. Yakushijin, Y. Inoue, T. Igura, K. Mochizuki, K. Imanaka, A. Kaneko, M. Oshita, H. Hagiwara, E. Mita, T. Nagase, T. Ito, Y. Inui, T. Hijioka, K. Katayama, S. Tamura, H. Yoshihara, Y. Imai, M. Kato, Y. Yoshida, T. Tatsumi, K. Ohkawa, S. Kiso, T. Kanto, A. Kasahara, T. Takehara and N. Hayashi

    Version of Record online : 22 JUN 2009, DOI: 10.1111/j.1365-2893.2009.01106.x

  13. You have free access to this content
    Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin

    British Journal of Clinical Pharmacology

    Volume 62, Issue 6, December 2006, Pages: 699–709, Eric Snoeck, Janet R. Wade, Frank Duff, Matthew Lamb and Karin Jorga

    Version of Record online : 16 AUG 2006, DOI: 10.1111/j.1365-2125.2006.02741.x

  14. Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus

    Intervention Review

    The Cochrane Library

    Alfonso Iorio, Emanuela Marchesini, Tahany Awad and Lise Lotte Gluud

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD004888.pub2

  15. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 2 DEC 2008, DOI: 10.1002/hep.22759

  16. You have free access to this content
    Poster Sessions

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 92A–207A,

    Version of Record online : 1 OCT 2013, DOI: 10.1002/hep.26726

  17. You have free access to this content
    Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon α-2b and ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1346–1353, A. MANGIA, O. DALGARD, N. MINERVA, H. VERBAAN, D. BACCA, H. RING-LARSEN, M. COPETTI, V. CARRETTA, V. PIAZZOLLA, R. COZZOLONGO, L. MOTTOLA and A. ANDRIULLI

    Version of Record online : 8 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04290.x

  18. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  19. You have free access to this content
    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

    HIV Medicine

    Volume 14, Issue S4, November 2013, Pages: 1–71, Writing Group, Dr Ed Wilkins, Dr Mark Nelson, Dr Kosh Agarwal, Ms Dola Awoyemi, Dr Eleanor Barnes, Dr Sanjay Bhagani, Dr Gary Brook, Dr Ashley Brown, Ms Sheena Castelino, Dr Graham Cooke, Prof Martin Fisher, Prof Anna Maria Geretti, Mr Robert James, Dr Ranjababu Kulasegaram, Prof Clifford Leen, Prof David Mutimer, Dr Chloe Orkin, Dr Emma Page, Dr Adrian Palfreeman, Dr Padmasayee Papineni, Dr Alison Rodger and Dr CY William Tong

    Version of Record online : 25 OCT 2013, DOI: 10.1111/hiv.12106

  20. You have free access to this content
    Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 30, Issue 5, September 2009, Pages: 487–494, D. BREILH, J. FOUCHER, L. CASTÉRA, P. TRIMOULET, S. DJABAROUTI, W. MERROUCHE, P. COUZIGOU, M.-C. SAUX and V. DE LÉDINGHEN

    Version of Record online : 11 JUN 2009, DOI: 10.1111/j.1365-2036.2009.04065.x